Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04975256 |
Title | Adagrasib in Combination With BI 1701963 in Patients With Cancer (KRYSTAL 14) |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Mirati Therapeutics Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Washington University School of Medicine | Saint Louis | Missouri | 63110 | United States | Details | |
The Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Next Oncology | San Antonio | Texas | 78229 | United States | Details |